THE ECONOMIST: Elon Musk has added almost $US40b to his fortune thanks to the soaring price of Tesla shares, but his is not the only company faring well.
First, drugs like Ozempic tackled diabetes. Then it was obesity. Now it’s cardiovascular and kidney disease, with Alzheimer’s and addiction on the horizon. The possibilities truly are endless.